# Vyne Therapeutics Inc. clinical trials: 32 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 32 trials with Vyne Therapeutics Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Vyne Therapeutics Inc.: 32 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/vyne-therapeutics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 32
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 32, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 10, 2024 | NCT06493578 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. | Vyne Therapeutics Inc. | Phase 2 | Terminated | Non-segmental Vitiligo | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06493578) |
| June 16, 2021 | NCT04927572 | Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis | Vyne Therapeutics Inc. | Phase 1/2 | Completed | Atopic Dermatitis | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04927572) |
| October 29, 2020 | NCT04608500 | A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular... | Vyne Therapeutics Inc. | Phase 3 | Completed | Facial Papulopustular Rosacea | 771 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04608500) |
| September 26, 2019 | NCT04104685 | A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. | Vyne Therapeutics Inc. | Phase 2 | Completed | Acne Vulgaris | 446 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04104685) |
| August 28, 2019 | NCT04070755 | Dermal Photo Allergic Skin Reaction | Vyne Therapeutics Inc. | Phase 1 | Completed | Healthy | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04070755) |
| August 28, 2019 | NCT04070742 | Dermal Phototoxicity Study | Vyne Therapeutics Inc. | Phase 1 | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04070742) |
| August 21, 2019 | NCT04064125 | Dermal Cumulative Irritant Patch Study | Vyne Therapeutics Inc. | Phase 1 | Completed | Healthy | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04064125) |
| August 12, 2019 | NCT04052711 | A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test... | Vyne Therapeutics Inc. | Phase 1 | Completed | Healthy | 233 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04052711) |
| February 15, 2019 | NCT03841331 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin | Vyne Therapeutics Inc. | Phase 2 | Completed | Pruritus | 233 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03841331) |
| November 15, 2018 | NCT03743038 | A Study Comparing Two Topicals in the Treatment of Acne Vulgaris | Vyne Therapeutics Inc. | Phase 1 | Completed | Acne Vulgaris | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03743038) |
| September 19, 2018 | NCT03677401 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | Vyne Therapeutics Inc. | Phase 3 | Completed | Pruritus, Prurigo Nodularis | 295 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03677401) |
| June 6, 2018 | NCT03546816 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | Vyne Therapeutics Inc. | Phase 3 | Completed | Pruritus, Prurigo Nodularis | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03546816) |
| May 30, 2018 | NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | Vyne Therapeutics Inc. | Phase 3 | Terminated | Pruritus, Prurigo Nodularis, Atopic Dermatitis, Psoriasis | 558 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03540160) |
| November 17, 2017 | NCT03343639 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis | Vyne Therapeutics Inc. | Phase 2 | Completed | Pruritus, Psoriasis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03343639) |
| September 14, 2017 | NCT03282591 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough | Vyne Therapeutics Inc. | Phase 2 | Completed | Refractory Chronic Cough | 185 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03282591) |
| September 8, 2017 | NCT03276936 | A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea | Vyne Therapeutics Inc. | Phase 3 | Completed | Papulopustular Rosacea | 504 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03276936) |
| September 1, 2017 | NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | Vyne Therapeutics Inc. | Phase 3 | Completed | Acne Vulgaris | 1,488 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03271021) |
| May 5, 2017 | NCT03142451 | A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular... | Vyne Therapeutics Inc. | Phase 3 | Completed | Facial Papulopustular Rosacea | 751 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03142451) |
| November 29, 2016 | NCT02975271 | Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury | Vyne Therapeutics Inc. | Phase 2 | Terminated | Pruritus, Burns | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02975271) |
| November 29, 2016 | NCT02975206 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis | Vyne Therapeutics Inc. | Phase 2 | Completed | Pruritus, Atopic Dermatitis | 484 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02975206) |
| June 28, 2016 | NCT02815280 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | Vyne Therapeutics Inc. | Phase 3 | Completed | Acne Vulgaris | 495 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02815280) |
| June 28, 2016 | NCT02815267 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | Vyne Therapeutics Inc. | Phase 3 | Completed | Acne Vulgaris | 466 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02815267) |
| November 11, 2015 | NCT02601963 | Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea | Vyne Therapeutics Inc. | Phase 2 | Completed | Rosacea, Papulopustular Rosacea | 233 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02601963) |
| September 26, 2014 | NCT02250859 | A Pharmacokinetic Study of Minocycline in Male and Female Volunteers | Vyne Therapeutics Inc. | Phase 1 | Completed | Acne | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02250859) |
| September 15, 2014 | NCT02239731 | Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients | Vyne Therapeutics Inc. | Phase 2 | Completed | Rash Due to Epidermal Growth Factor Receptor Inhibitors | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02239731) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 1/2 | 1 |
| Phase 2 | 16 |
| Phase 3 | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 27 |
| Terminated | 5 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pruritus | 7 |
| Acne Vulgaris | 7 |
| Dermatitis, Atopic | 4 |
| cyclopia sequence | 3 |
| Rosacea | 3 |
| Psoriasis | 2 |
| Vitiligo | 1 |
| Impetigo | 1 |
| Exanthema | 1 |
| Urinary Incontinence | 1 |
| Urinary Bladder, Overactive | 1 |
| Burns | 1 |
| Lichenoid Eruptions | 1 |
| Alcoholism | 1 |
| Chronic Cough | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pubs in the United States](https://specstream.ai/data/businesses/pubs/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [Salad bars in the United States](https://specstream.ai/data/businesses/salad-bars/united-states)
- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
- [Indian restaurants in the United States](https://specstream.ai/data/businesses/indian-restaurants/united-states)
